Unit of Clinical Epidemiology, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic and Maternal Infantile Sciences (DINOGMI), University of Genova, Genova, Italy.
J Clin Epidemiol. 2024 Sep;173:111465. doi: 10.1016/j.jclinepi.2024.111465. Epub 2024 Jul 15.
Reporting bias, prevalent in biomedical fields, can undermine evidence credibility. Our objective was to evaluate the proportion of discrepancies between registered protocols and published manuscripts in randomized controlled trials (RCTs) on exercise interventions for patients with chronic low back pain (CLBP).
We conducted a cross-sectional meta-research study, starting from the 2021 "Exercise therapy for CLBP" Cochrane Review. We selected all RCTs reporting a protocol registration on a primary register of the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) or in ClinicalTrials.gov. We extracted data from both registered protocol and published manuscript of RCTs, collecting recruitment and administrative information (eg, record dates) and details of trial characteristics (eg, outcomes, arms, statistical analysis plan details [SAPs]). Independent pairs of reviewers assessed discrepancies between registered protocol and published manuscript for the reporting of primary and secondary outcomes domains, measurement instruments, time-points, number of arms and SAPs(if attached). Outcome discrepancies were characterized as addition, omission, upgrade or downgrade.
We included 116 RCTs reporting an available protocol registration. Overall, 100 RCTs (86.2%) distinguished between primary and secondary outcomes. Of these, 39 RCTs (39.0%) reported one or more discrepancies in primary outcomes, and 78 RCTs (78.0%) reported one or more discrepancies in secondary outcomes. Focusing on discrepancies for the primary outcome, 64.5% of added, upgraded or downgraded outcomes favored statistically significant effects. Few RCTs (n = 6) reported discrepancies in the number of arms. SAPs were poorly reported in the registered protocols (n = 3) for being compared to the publications.
We found substantial outcome discrepancies comparing registered protocols and published manuscripts in RCTs assessing exercise interventions for patients with CLBP, with some impacting the statistical significance of the effects. Readers are encouraged to approach RCTs results in this field with caution.
在生物医学领域中,报告偏倚较为常见,这可能会降低证据的可信度。本研究旨在评估慢性下背痛(CLBP)患者运动干预的随机对照试验(RCT)中,注册方案与已发表的手稿之间存在差异的比例。
我们进行了一项横断面元研究,从 2021 年“CLBP 的运动治疗” Cochrane 综述开始。我们选择了所有报告在世界卫生组织(WHO)国际临床试验注册平台(ICTRP)或 ClinicalTrials.gov 上注册的主要注册处的 RCT。我们从 RCT 的注册方案和已发表的手稿中提取数据,收集招募和行政信息(例如记录日期)以及试验特征的详细信息(例如结局、试验组、统计分析计划细节[SAP])。独立的评审员评估了注册方案和已发表的手稿在主要和次要结局领域、测量工具、时间点、试验组数量和 SAP(如有)报告方面的差异。结局差异的特征为添加、遗漏、升级或降级。
我们纳入了 116 项报告了可用方案注册的 RCT。总体而言,有 100 项 RCT(86.2%)区分了主要和次要结局。其中,39 项 RCT(39.0%)报告了主要结局方面的一个或多个差异,78 项 RCT(78.0%)报告了次要结局方面的一个或多个差异。在主要结局的差异方面,64.5%的添加、升级或降级结局有利于具有统计学意义的效果。少数 RCT(n=6)报告了试验组数量的差异。与出版物相比,注册方案中仅 3 项报告了 SAP。
我们发现,在评估 CLBP 患者运动干预的 RCT 中,与注册方案相比,已发表的手稿中存在大量结局差异,其中一些影响了效果的统计学意义。鼓励读者在处理该领域的 RCT 结果时保持谨慎。